Picture of Valerio Therapeutics SA logo

ALVIO — Valerio Therapeutics SA News Story

0.000.00%
fr flag iconLast trade - 00:00
HealthcareHighly SpeculativeSmall CapMomentum Trap

Brief: Onxeo Receives U.S. Patent And Trademark Office Notice Of Allowance For New Patent Protecting Asidna™

Nov 4 (Reuters) - ONXEO SA  C4X.PA :
    * ONXEO RECEIVES U.S. PATENT AND TRADEMARK OFFICE NOTICE OF
ALLOWANCE FOR NEW PATENT PROTECTING COMBINATION OF ASIDNA™ WITH
ANY PARP INHIBITOR FOR CANCER TREATMENT
    * NEW U.S. PATENT, IS VALID UNTIL 2036
    * IT FURTHER EXPANDS ONXEO'S INTELLECTUAL PROPERTY PORTFOLIO
FOR
ASIDNA™, WHICH NOW INCLUDES 168 NUMBER OF PATENTS GLOBALLY.

Source text for Eikon:  ID:nBw4Fdzjba 
Further company coverage:  C4X.PA 

 (Gdansk Newsroom)
 ((Gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))

Recent news on Valerio Therapeutics SA

See all news